Abstract:Endometrial carcinoma (EC) often exhibits resistance to hormone therapies, such as medroxyprogesterone acetate (MPA), highlighting the need for novel strategies to enhance therapeutic efficacy. The present study aimed to investigate the effects of polyphyllin VII (PPVII) on the efficacy of MPA in EC, focusing on the regulatory role of microRNA (miR)‐33a‐5p. Briefly, an MPA‐resistant Ishikawa cell line (Ishikawa/MPA‐R), maintained with 10 μM MPA, was established and transfected with negative control (NC) and miR‐33a‐5p inhibitors. Following treatment with PPVII and MPA, the proliferation capacity and apoptosis levels of the Ishikawa and Ishikawa/MPA‐R cells were evaluated using reverse transcription‐quantitative polymerase chain reaction, MTT assay, clonogenic assay, flow cytometry, western blotting and dual‐luciferase assay. Next, the expression levels of miR‐33a‐5p and F‐box and leucine rich repeat protein 16 (FBXL16) were measured, and the regulatory relationship between miR‐33a‐5p and FBXL16 was analyzed. Significant reductions in cell viability were observed in all groups following treatment with increased concentrations of MPA and PPVII, with the greatest effect observed in the combined MPA + PPVII group (P<0.01). The apoptosis levels of the Ishikawa/MPA‐R cells were significantly increased in all drug treatment groups, particularly in the MPA + PPVII group (P<0.05). PPVII treatment significantly increased the expression level of miR‐33a‐5p in Ishikawa/MPA‐R cells (P<0.01). In the PPVII + miR‐33a‐5p inhibitor group, the Ishikawa/MPA‐R cells exhibited an upregulation in the viability (P<0.01), colony formation ability (P<0.01), proportion in the G1 phase (P<0.05) and the protein expression levels of cyclin D1 (P<0.01) and cyclin‐dependent kinase 4 (P<0.01), and a reduction in the miR‐33a‐5p expression (P<0.01), apoptosis levels (P<0.05), proportion in the S (P<0.05) and G2 phases and the levels of Bcl‐2‐associated X protein (P<0.001). The FBXL16 protein expression in Ishikawa/MPA‐R cells was significantly higher compared with Ishikawa cells, and the mRNA and protein expression levels of FBXL16 were markedly elevated in the PPVII + miR‐33a‐5p inhibitor group compared with the PPVII + NC group (P<0.01). These findings suggested that PPVII upregulated the expression of miR‐33a‐5p, enhanced the sensitivity of EC cells to MPA and potentially exerted anticancer effects in EC through the synergistic action of the miR‐33a‐5p/FBXL16 axis in combination with MPA.

[Study of Mechanism of Medroxyprogesterone 17-Acetate on the Cancer Stem Cell-Like Properties of Human Endometrial Cancer].

[Influence of Long-Term Treatment with MPA on the Biological Character of Endometrial Carcinoma Ishikawa Cell].

Study of the Characterization of Side Population Cells in Endometrial Cancer Cell Lines: Chemoresistance, Progestin Resistance, and Radioresistance

Mechanism study of PRB in regulating therapeutic sensitivity of MPA in endometrial cancer cells

Effect of Medroxyprogesterone Acetate on Proliferation and Apoptosis of Human Colorectal Cancer Cells

The study of arsenic trioxide on the effect at medroxyprogesterone acetate resistant endometrial carcinoma cells

TRPS1 Regulates the Opposite Effect of Progesterone Via RANKL in Endometrial Carcinoma and Breast Carcinoma

Epidermal Growth Factor Receptor Signaling Enhanced by Long-Term Medroxyprogesterone Acetate Treatment in Endometrial Carcinoma.

Chlorpromazine Sensitizes Progestin-Resistant Endometrial Cancer Cells to MPA by Upregulating PRB

Polyphyllin VII enhances the sensitivity of endometrial carcinoma cells to medroxyprogesterone acetate through upregulating miR‐33a‐5p expression

[Mechanism of Thioridazine Plus Medroxyprogesterone in the Treatment of Endometrial Cancer].

Experimental Study of the Inhibitory Effect of Medroxyprogesterone Acetate on the Growth of Human Colon Cancer LS174T Cell Xenografts

Sterol Regulatory Element-Binding Protein–1/Fatty Acid Synthase Involvement in Proliferation Inhibition and Apoptosis Promotion Induced by Progesterone in Endometrial Cancer

Delineation Of Biological And Molecular Mechanisms Underlying The Diverse Anticancer Activities Of Mycophenolic Acid

Breast Cancer Resistance Protein-Mediated 5-Fluorouracil Resistance and Its Mechanism

Comprehensive bioinformatics analysis of acquired progesterone resistance in endometrial cancer cell line

Programmed Cell Death-1 Inhibitor Combination Treatment for Recurrent Proficient Mismatch Repair/ Miscrosatellite-Stable Type Endometrial Cancer: A Case Report.

MPA influences tumor cell proliferation, migration, and invasion induced by RANKL through PRB involving the MAPK pathway in endometrial cancer.

Enhancement of the antitumor effect of cisplatin against the drug-resistant human ovarian cancer cells CoC1/cDDP by medroxyprogesterone acetate in vivo.

5-Aza-2 '-Deoxycytidine Improves The Sensitivity Of Endometrial Cancer Cells To Progesterone Therapy

Hsa_Circ_0001860 Promotes Smad7 to Enhance MPA Resistance in Endometrial Cancer <i>via</i> miR-520h